Australia's SpeeDx raises $15m from US-based Northpond
SpeeDx, an Australian developer of molecular diagnostics solutions, has raised $15 million from US-based VC firm Northpond Ventures across two tranches.
Founded in 2009, SpeeDx focuses on in vitro diagnostic tests involving molecules that bind to certain chemicals, creating radiological markers that allow for the detection of diseases in real time. Its...
More on Australasia
Latest News
Fund focus: Kotak exploits distressed assets edge
Kotak Mahindra Group hopes his longstanding experience in financial services will serve as a differentiator as it looks for deals in India's increasingly popular distressed space
Sovereign investors and technology: Smart nations
Conservative sovereign wealth investors are increasingly comfortable making direct commitments to venture-oriented technology companies. The strategy appears to suit them but remains to be validated
China's 01VC pursues industrial upgrade strategy
01VC has secured institutional LP support for its second fund, which closed at $100 million. The early-stage investor plans to deploy it across industrial and enterprise deals in China and Southeast Asia